Aurora Cannabis Announces Date of Annual Basic Meeting



EDMONTON, Sept. 20, 2019 /CNW/ – Aurora Cannabis Inc. (the “Business” or “Aurora“) (NYSE | TSX: ACB), the Canadian business defining the future of cannabis worldwide, currently announced that it will hold its Annual Basic Meeting of shareholders (the “Meeting”) on Friday, November eightth, 2019 at 10:00am MT. All registered shareholders are welcome to attend at the Renaissance Hotel positioned at 4236 36 St E, Edmonton International Airport, AB T9E 0V4. In conjunction with the Meeting, Aurora has filed its Info Circular and associated proxy supplies which are offered for download below its profile on each SEDAR and EDGAR.

The Business also announced currently that it has granted an aggregate of two,114,703 stock solutions, 33,186 deferred share units (“DSUs”) and 376,895 restricted share units (“RSUs”) to directors and officers of the Business. The stock solutions are exercisable at a price tag of $7.91 per share for a period of 5 years from the date of grant. Each solutions and RSUs vest annually more than 36 months and the DSUs vest quarterly more than 12 months.

About Aurora 

Headquartered in Edmonton, Alberta, Canada with funded capacity in excess of 625,00 kg per annum and sales and operations in 25 nations across 5 continents, Aurora is a single of the world’s biggest and major cannabis corporations. Aurora is vertically integrated and horizontally diversified across just about every important segment of the worth chain, from facility engineering and design and style to cannabis breeding and genetics study, cannabis and hemp production, derivatives, higher worth-add solution improvement, dwelling cultivation, wholesale and retail distribution.

Hugely differentiated from its peers, Aurora has established a uniquely sophisticated, constant and effective production approach, primarily based on goal-constructed facilities that integrate major-edge technologies across all processes, defined by in depth automation and customization, resulting in the enormous scale production of higher-excellent constant solution. Made to be replicable and scalable globally, our production facilities are created to generate cannabis at substantial scale, with higher excellent, sector-major yields, and low-per gram production expenses. Every single of Aurora’s facilities is constructed to meet European Union Fantastic Manufacturing Practices (“EU GMP”) requirements. Certification has been granted to Aurora’s very first production facility in Mountain View County, the MedReleaf Markham facility, and its wholly owned European health-related cannabis distributor Aurora Deutschland. All Aurora facilities are created and constructed to the EU GMP typical.

In addition to the Company’s fast organic development and sturdy execution on strategic M&ampA, which to date consists of 17 wholly owned subsidiary corporations – MedReleaf, CanvasRX, Peloton Pharmaceutical, Aurora Deutschland, H2 Biopharma, BC Northern Lights, Larssen Greenhouses, CanniMed Therapeutics, Anandia, HotHouse Consulting, MED Colombia, Agropro, Borela, ICC Labs, Whistler, Chemi Pharmaceutical, and Hempco – Aurora is distinguished by its reputation as a companion and employer of option in the worldwide cannabis sector, getting invested in and established strategic partnerships with a variety of major innovators, like: Radient Technologies Inc. (TSXV: RTI), Cann Group Ltd. (ASX: CAN), Micron Waste Technologies Inc. (CSE: MWM), Choom Holdings Inc. (CSE: CHOO), CTT Pharmaceuticals (OTCC: CTTH), Alcanna Inc. (TSX: CLIQ), Higher Tide Inc. (CSE: HITI), EnWave Corporation (TSXV: ENW), Capcium Inc. (private), Evio Beauty Group (private), and Wagner Dimas (private).

Aurora’s Widespread Shares trade on the TSX and NYSE below the symbol “ACB”, and is a constituent of the S&ampP/TSX Composite Index.

For far more facts about Aurora, please take a look at our investor site,

Terry Booth, CEO       

Aurora Cannabis Inc. 

Forward Searching Statements .

This news release consists of statements containing specific “forward-hunting information” inside the which means of applicable securities law (“forward-hunting statements”). Forward-hunting statements are often characterized by words such as “plan”, “continue”, “expect”, “project”, “intend”, “believe”, “anticipate”, “estimate”, “may”, “will”, “potential”, “proposed” and other comparable words, or statements that specific events or situations “may” or “will” happen. These statements are only predictions. Several assumptions have been applied in drawing the conclusions or creating the projections contained in the forward-hunting statements all through this news release. Forward-hunting statements are primarily based on the opinions and estimates of management at the date the statements are produced, and are topic to a assortment of dangers and uncertainties and other variables that could bring about actual events or final results to differ materially from these projected in the forward-hunting statements. The Business is below no obligation, and expressly disclaims any intention or obligation, to update or revise any forward-hunting statements, no matter whether as a outcome of new facts, future events or otherwise, except as expressly needed by applicable law.

Neither TSX, NYSE nor their applicable Regulation Solutions Providers (as that term is defined in the policies of the Toronto Stock Exchange and New York Stock Exchange) accept duty for the adequacy or accuracy of this release.

Cision View original content material to download multimedia:

Supply Aurora Cannabis Inc.

View original content material to download multimedia:

For Media: Heather MacGregor, +1.416.509.5416, heather[email protected] For Investors: Rob Kelly, +1.647.331.7228, [email protected] CNW Group 2019


Latest posts